India's corona vaccine is in Phase II clinical trial: Drug markers are asked to submit their specific prices.
India is having the two indigenous vaccines applicants the covaxine by the Bharat Biotech and ZyCOV-D by the Zydus Cadila. There has been a competition between the two authorizations of the Phase II trials.
India is leaving no effort upon developing a vaccine against the pandemic of coronavirus infection. the ICMR officials on Wednesday have reported the parliamentary panel about the successful Phase II trial.
Indian Council of Medical Research (ICMR) Director-General Balram Bhargava informed members of the parliamentary standing committee on home affairs that the vaccine candidates developed by Bharat Biotech, Cadila, and the Serum Institute of India are at different stages of the trial, said an MP present in the meeting, PTI reported.
After the launch of the COVID-19 vaccine by Russia on the assistance of Vladamir Putin without proper rounds of trials have been facing several rounds of controversy as proper data wasnt provided after the Phase 1 trial.
After the vaccine would be launched the vaccine would be given to Doctors, Teachers, and members holding important positions this is to ensure check and the government has promised to check up on the rates and evaluate it properly.
All the nations are working hard on this goal to find a proper corona vaccine so that it gets patent to sell for other nations, based on this the IMCR is also not leaving any stone unturned to find out the famine by human trails phase 2 and entering into phase 3 trial.